Cargando...
Rosiglitazone accelerates wound healing by improving endothelial precursor cell function and angiogenesis in db/db mice
BACKGROUND & AIMS: Endothelial precursor cell (EPC) dysfunction is one of the risk factors for diabetes mellitus (DM) which results in delayed wound healing. Rosiglitazone (RSG) is a frequently prescribed oral glucose-lowering drug. Previous studies have shown the positive effects of RSG on amel...
Guardado en:
| Publicado en: | PeerJ |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
PeerJ Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6800979/ https://ncbi.nlm.nih.gov/pubmed/31637120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.7815 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|